Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer

NCT00003928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: cisplatin
DRUG: gemcitabine hydrochloride

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]